Grape King Bio Ltd. Statistics
Grape King Bio Ltd. (1707) Stock Statistics & Valuation Metrics
Total Valuation
Grape King Bio Ltd. has a market cap or net worth of TWD 11.93B. The enterprise value is TWD 11.53B.
- Market Cap
- TWD 11.93B
- Enterprise Value
- TWD 11.53B
Share Statistics
Grape King Bio Ltd. has 148,137,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 148,137,370
- Owned by Insiders
- ―
- Owned by Institutions
- 3.16%
Financial Efficiency
Grape King Bio Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 14.00%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 14.00%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 20.46M
- Profits Per Employee
- 2.43M
- Employee Count
- 501
- Asset Turnover
- 0.65
- Inventory Turnover
- 2.61
Valuation Ratios
The current PE Ratio of Grape King Bio Ltd. is 10.39. Grape King Bio Ltd.’s PEG ratio is -0.72.
- PE Ratio
- 10.39
- PS Ratio
- 1.18
- PB Ratio
- 1.16
- Price to FCF
- 7.98
- Price to Operating Cash Flow
- 5.99
- PEG Ratio
- -0.72
Income Statement
In the last 12 months, Grape King Bio Ltd. had revenue of 10.25B and earned 1.22B in profits. Earnings per share was 8.22.
- Revenue
- 10.25B
- Gross Profit
- 7.70B
- Operating Income
- 2.14B
- Pretax Income
- 2.30B
- Net Income
- 1.22B
- EBITDA
- 2.69B
- Earnings Per Share (EPS)
- 8.22
Cash Flow
In the last 12 months, operating cash flow was 1.99B and capital expenditures -496.78M, giving a free cash flow of 1.50B billion.
- Operating Cash Flow
- 1.99B
- Free Cash Flow
- 1.50B
- Free Cash Flow per Share
- 10.09
Dividends & Yields
Grape King Bio Ltd. pays an annual dividend of ―, resulting in a dividend yield of 7.45%
- Dividend Per Share
- ―
- Dividend Yield
- 7.45%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 12.54%
- Earnings Yield
- 9.63%
Stock Price Statistics
- Beta
- 0.11
- 52-Week Price Change
- -35.60%
- 50-Day Moving Average
- 86.39
- 200-Day Moving Average
- 99.69
- Relative Strength Index (RSI)
- 27.30
- Average Volume (3m)
- 386.22K
Important Dates
Grape King Bio Ltd. upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Grape King Bio Ltd. as a current ratio of 1.65, with Debt / Equity ratio of 2.08%
- Current Ratio
- 1.65
- Quick Ratio
- 1.37
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.47
- Interest Coverage Ratio
- 457.49
Taxes
In the past 12 months, Grape King Bio Ltd. has paid 436.76M in taxes.
- Income Tax
- 436.76M
- Effective Tax Rate
- 0.19
Enterprise Valuation
Grape King Bio Ltd. EV to EBITDA ratio is 3.26, with an EV/FCF ratio of 5.73.
- EV to Sales
- 0.85
- EV to EBITDA
- 3.26
- EV to Free Cash Flow
- 5.73
- EV to Operating Cash Flow
- 4.30
Balance Sheet
Grape King Bio Ltd. has TWD 3.70B in cash and marketable securities with TWD 186.69M in debt, giving a net cash position of TWD 3.52B billion.
- Cash & Marketable Securities
- TWD 3.70B
- Total Debt
- TWD 186.69M
- Net Cash
- TWD 3.52B
- Net Cash Per Share
- TWD 23.74
- Tangible Book Value Per Share
- TWD 77.62
Margins
Gross margin is 72.88%, with operating margin of 20.14%, and net profit margin of 11.34%.
- Gross Margin
- 72.88%
- Operating Margin
- 20.14%
- Pretax Margin
- 21.63%
- Net Profit Margin
- 11.34%
- EBITDA Margin
- 26.00%
- EBIT Margin
- 20.50%
Analyst Forecast
The average price target for Grape King Bio Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -5.38%
- EPS Growth Forecast
- -12.80%
